ArticleAntibiotics (Basel, Switzerland)2022

TXH11106: A Third-Generation MreB Inhibitor with Enhanced Activity against a Broad Range of Gram-Negative Bacterial Pathogens.

Eric J Bryan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.